NEWS

August 9, 2022

Pub giant’s $11m Darwin deal faces competition scrutiny

DARWIN: An inquiry by the competition regulator into a proposed acquisition of a ... read more

August 9, 2022

ISS backs Pfizer’s $179m ResApp takeover offer

MELBOURNE: Institutional Shareholder Services has backed Pfizer’s $179m takeover of a fledgling biotech ... read more

August 9, 2022

Genesis Capital backs in clinical research with Crux Biolabs deal

MELBOURNE: The biolabs deals are back! After a short hiatus, specialist healthcare private ... read more

August 9, 2022

Appen’s latest downgrade points to bigger problem

MELBOURNE: ASX-listed AI data firm Appen clearly has several serious problems, starting with ... read more